Once-Daily MMX Mesalamine in the Management of Ulcerative colitis

Mesalamine (5-ASA) has been the mainstay therapy of mild to moderate active ulcerative colitis both as an induction and maintenance treatment. Multimatrix system (MMX) 5-ASA is a recently developed formulation of 5-ASA allowing for slow and gradual release of 5-ASA throughout the entire colon. This...

Full description

Bibliographic Details
Main Authors: Wojciech Blonski, Anna M. Buchner, Gary R. Lichtenstein
Format: Article
Language:English
Published: SAGE Publishing 2011-01-01
Series:Clinical Medicine Insights: Gastroenterology
Online Access:https://doi.org/10.4137/CGast.S4276